Sunghae Park
8Patents
1h-index
19Co-inventors
40Inventor score
Filing activity: Mar 11, 2014 → Feb 16, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10844115B2 | Bone-targeting antibodies | Chemistry; Metallurgy | 2 | Active |
| US12098194B2 | Bone-targeting antibodies | Chemistry; Metallurgy | 0 | Active |
| US9783604B2 | Engineered anti-TGF-beta antibodies and antigen-binding fragments | Chemistry; Metallurgy | 0 | Active |
| US12227560B2 | Anti-CHIKV antibodies and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10730936B2 | Engineered anti-TGF-β antibodies and antigen-binding fragments | Chemistry; Metallurgy | 0 | Active |
| US11505611B2 | FGFR3 antibodies and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US11286295B2 | Anti-CHIKV monoclonal antibodies directed against the E2 structural protein | Emerging Cross-Sectional Technologies | 0 | Active |
| US11879004B2 | Modified binding polypeptides for optimized drug conjugation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.